Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung × Ifosfamide × 90 days × Clear all

NCT04224337 2025-12-31

Phase II Study of Durvalumab ,Doxorubicin, and Ifosfamide in Pulmonary Sarcomatoid Carcinoma

Phase 2 Completed

Carcinoma, Non-Small-Cell Lung